EA200900293A1 - Композиции с повышенной способностью размягчения тканей - Google Patents

Композиции с повышенной способностью размягчения тканей

Info

Publication number
EA200900293A1
EA200900293A1 EA200900293A EA200900293A EA200900293A1 EA 200900293 A1 EA200900293 A1 EA 200900293A1 EA 200900293 A EA200900293 A EA 200900293A EA 200900293 A EA200900293 A EA 200900293A EA 200900293 A1 EA200900293 A1 EA 200900293A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
ability
tissues
vagina
risk
Prior art date
Application number
EA200900293A
Other languages
English (en)
Other versions
EA014971B1 (ru
Inventor
Федерико Маилланд
Паоло Маскаруччи
Эмануэла Мура
Original Assignee
Полихем С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Полихем С.А. filed Critical Полихем С.А.
Publication of EA200900293A1 publication Critical patent/EA200900293A1/ru
Publication of EA014971B1 publication Critical patent/EA014971B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Композиции для повышения эластичности вагины и промежности во время последних трех месяцев беременности включают сочетание тиолатного соединения или его смеси со сложным эфиром органической кислоты или его смеси. Композиции, предлагаемые в данном изобретении, повышают свойства эластичности тканей вагины и/или промежности в смысле как повышения растяжимости, так и более быстрого упругого восстановления. Композиции, предлагаемые в данном изобретении, могут понижать риск травмирования тканей промежности во время родов, а также риск недержания кала или мочи как послеродового осложнения на краткий/средний/длительный срок.
EA200900293A 2006-08-09 2007-04-18 Композиции, способствующие повышенной эластичности тканей EA014971B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20060118649 EP1886676A1 (en) 2006-08-09 2006-08-09 Compositions with enhanced elasticizing activity
PCT/EP2007/053793 WO2008017521A2 (en) 2006-08-09 2007-04-18 Compositions with enhanced elasticizing activity

Publications (2)

Publication Number Publication Date
EA200900293A1 true EA200900293A1 (ru) 2009-06-30
EA014971B1 EA014971B1 (ru) 2011-04-29

Family

ID=37575000

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900293A EA014971B1 (ru) 2006-08-09 2007-04-18 Композиции, способствующие повышенной эластичности тканей

Country Status (23)

Country Link
US (1) US9125806B2 (ru)
EP (2) EP1886676A1 (ru)
JP (2) JP2010500309A (ru)
KR (2) KR101521166B1 (ru)
CN (1) CN101500550B (ru)
AR (1) AR062304A1 (ru)
AT (1) ATE457723T1 (ru)
BR (1) BRPI0715182C1 (ru)
CA (1) CA2655472C (ru)
CY (1) CY1110032T1 (ru)
DE (1) DE602007004857D1 (ru)
DK (1) DK2049092T3 (ru)
EA (1) EA014971B1 (ru)
ES (1) ES2340335T3 (ru)
HK (1) HK1126956A1 (ru)
HR (1) HRP20100212T1 (ru)
MX (1) MX2009000869A (ru)
NO (1) NO343143B1 (ru)
PL (1) PL2049092T3 (ru)
PT (1) PT2049092E (ru)
RS (1) RS51282B (ru)
SI (1) SI2049092T1 (ru)
WO (1) WO2008017521A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3081212A1 (en) 2015-04-16 2016-10-19 Polichem SA Carboxymethylcysteine for topical treatment of stretch marks
EP3442501A1 (en) 2016-04-15 2019-02-20 Fairhaven Health, LLC Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
IT202100002285A1 (it) * 2021-02-03 2022-08-03 Farm Dott Ferretti Stefano Nuova composizione

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617639A1 (de) * 1966-09-12 1972-04-20 Mini Ind Chimice Verfahren zur Herstellung eines Arzneimittels zur Behandlung von physiologischen Hautkrankheiten
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
GB9213472D0 (en) * 1992-06-25 1992-08-12 Unilever Plc Cosmetic composition
WO1995034280A1 (en) * 1994-06-15 1995-12-21 The Procter & Gamble Company Methods of lightening hyperpigmented regions in mammalian skin
JP3542665B2 (ja) * 1995-07-07 2004-07-14 株式会社資生堂 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
FR2740340B1 (fr) * 1995-10-30 1997-12-05 Oreal Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
US20050266064A1 (en) * 2004-05-29 2005-12-01 Mccarthy Kathryn J Cosmetic compositions and methods
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
BRPI0515846B1 (pt) * 2004-10-25 2020-10-20 Unilever N.V composição de higiene pessoal
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin

Also Published As

Publication number Publication date
BRPI0715182A2 (pt) 2012-12-25
HRP20100212T1 (hr) 2010-05-31
ATE457723T1 (de) 2010-03-15
NO20091011L (no) 2009-03-06
EA014971B1 (ru) 2011-04-29
EP2049092A2 (en) 2009-04-22
CY1110032T1 (el) 2015-01-14
SI2049092T1 (sl) 2010-04-30
DE602007004857D1 (de) 2010-04-01
HK1126956A1 (en) 2009-09-18
KR20090050065A (ko) 2009-05-19
JP2010500309A (ja) 2010-01-07
WO2008017521A3 (en) 2008-05-22
CN101500550A (zh) 2009-08-05
NO343143B1 (no) 2018-11-19
CA2655472C (en) 2014-10-21
PT2049092E (pt) 2010-04-21
JP5771649B2 (ja) 2015-09-02
EP2049092B1 (en) 2010-02-17
US20090291931A1 (en) 2009-11-26
CN101500550B (zh) 2011-12-14
JP2013227334A (ja) 2013-11-07
BRPI0715182B1 (pt) 2020-07-28
KR101521166B1 (ko) 2015-05-19
PL2049092T3 (pl) 2010-07-30
BRPI0715182B8 (pt) 2020-08-11
AR062304A1 (es) 2008-10-29
RS51282B (sr) 2010-12-31
WO2008017521A2 (en) 2008-02-14
EP1886676A1 (en) 2008-02-13
KR20140046080A (ko) 2014-04-17
CA2655472A1 (en) 2008-02-14
MX2009000869A (es) 2009-02-04
BRPI0715182C1 (pt) 2021-05-25
ES2340335T3 (es) 2010-06-01
DK2049092T3 (da) 2010-05-10
US9125806B2 (en) 2015-09-08

Similar Documents

Publication Publication Date Title
Hoebeke et al. Impact of sex reassignment surgery on lower urinary tract function
EA200601802A1 (ru) Производные морфолина
Firoozi et al. Purely transvaginal/perineal management of complications from commercial prolapse kits using a new prostheses/grafts complication classification system
BRPI0404688B8 (pt) composição para tratamento vaginal, uso da mesma, óvulo de tratamento, creme de tratamento, tampão vaginal para tratamento, e, forro de calcinha para tratamento
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
BR112013007446A2 (pt) afastador minimamente obstrutivo
BRPI0506713A (pt) composições de ácido peroxicarboxìlico de cadeia média
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
EA200900293A1 (ru) Композиции с повышенной способностью размягчения тканей
EP1886631A4 (en) SUB-URETRAL RIBBON FOR THE SURGICAL TREATMENT OF FEMININE URINARY INCONTINENCE AND SURGICAL INSTRUMENTS FOR THE IMPLEMENTATION OF THIS RIBBON
Mohammed et al. Prolapse surgery in octogenarians: are we pushing the limits too far?
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
ATE552833T1 (de) Methoxypolyethylenglykol-thioester-chelat und dessen verwendung
BR0215189A (pt) Combinações de viscoelásticos para uso durante cirurgia
RU2011127304A (ru) Способ реконструкции наружных женских половых органов при вирилизации наружных половых органов у девочек
RU2003112195A (ru) Способ пластики мочеиспускательного канала по поводу его протяженной или рецидивирующей стриктуры, облитерации или свища
Tijani et al. Penile fasciocutaneous flap urethroplasty: recent experience and challenges in a sub-Saharan African teaching hospital
Perovic et al. Vaginoplasty in male to female transsexuals using penile skin and urethral flap
RU2010120687A (ru) Предупреждение рецидивов сужения уретры после классического лечения
RU2008114394A (ru) Лечение стрессового недержания мочи и смешанного недержания мочи
DE502007003367D1 (de) Pharmazeutische zusammensetzung zur behandlung von inkontinenz
NO20062199L (no) Fiskefôr med tilsetningskomponent for a unnga soyaindusert tarmbetennelse
RU2004123496A (ru) Способ остеосакровагиноспексии при трансвагинальной гистерэктомии
Anwar et al. To find out the Incidence of Erectile Dysfunction among patients of Stricture Urethra
Starck-Söndergaard Endosonography of the anal spincter in women with particular reference to obstetric sphincter tears

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ